IBDEI12L ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,19161,0)
 ;;=733.82^^125^1230^10
 ;;^UTILITY(U,$J,358.3,19161,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19161,1,3,0)
 ;;=3^733.82
 ;;^UTILITY(U,$J,358.3,19161,1,5,0)
 ;;=5^Nonunion of fracture
 ;;^UTILITY(U,$J,358.3,19161,2)
 ;;=^83875
 ;;^UTILITY(U,$J,358.3,19162,0)
 ;;=173.70^^125^1230^1
 ;;^UTILITY(U,$J,358.3,19162,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19162,1,3,0)
 ;;=3^173.70
 ;;^UTILITY(U,$J,358.3,19162,1,5,0)
 ;;=5^Neoplasm, Skin Lower Limb
 ;;^UTILITY(U,$J,358.3,19162,2)
 ;;=^340603
 ;;^UTILITY(U,$J,358.3,19163,0)
 ;;=356.8^^125^1230^6
 ;;^UTILITY(U,$J,358.3,19163,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19163,1,3,0)
 ;;=3^356.8
 ;;^UTILITY(U,$J,358.3,19163,1,5,0)
 ;;=5^Neuropathy, Idiopathic Perip,Oth Spec
 ;;^UTILITY(U,$J,358.3,19163,2)
 ;;=^268525
 ;;^UTILITY(U,$J,358.3,19164,0)
 ;;=703.0^^125^1231^1
 ;;^UTILITY(U,$J,358.3,19164,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19164,1,3,0)
 ;;=3^703.0
 ;;^UTILITY(U,$J,358.3,19164,1,5,0)
 ;;=5^Onychocryptosis (Ingrown toe nail)
 ;;^UTILITY(U,$J,358.3,19164,2)
 ;;=^81221
 ;;^UTILITY(U,$J,358.3,19165,0)
 ;;=757.5^^125^1231^2
 ;;^UTILITY(U,$J,358.3,19165,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19165,1,3,0)
 ;;=3^757.5
 ;;^UTILITY(U,$J,358.3,19165,1,5,0)
 ;;=5^Onchodystrophy/Onycholysis; Congenital
 ;;^UTILITY(U,$J,358.3,19165,2)
 ;;=^273090
 ;;^UTILITY(U,$J,358.3,19166,0)
 ;;=703.8^^125^1231^3
 ;;^UTILITY(U,$J,358.3,19166,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19166,1,3,0)
 ;;=3^703.8
 ;;^UTILITY(U,$J,358.3,19166,1,5,0)
 ;;=5^Onchodystrophy/Onycholysis; Acquired
 ;;^UTILITY(U,$J,358.3,19166,2)
 ;;=^271926
 ;;^UTILITY(U,$J,358.3,19167,0)
 ;;=110.1^^125^1231^4
 ;;^UTILITY(U,$J,358.3,19167,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19167,1,3,0)
 ;;=3^110.1
 ;;^UTILITY(U,$J,358.3,19167,1,5,0)
 ;;=5^Onychomycosis
 ;;^UTILITY(U,$J,358.3,19167,2)
 ;;=^33173
 ;;^UTILITY(U,$J,358.3,19168,0)
 ;;=715.37^^125^1231^6
 ;;^UTILITY(U,$J,358.3,19168,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19168,1,3,0)
 ;;=3^715.37
 ;;^UTILITY(U,$J,358.3,19168,1,5,0)
 ;;=5^Osteoarthrosis, localized, not specified whether primary or secondary; ankle/foot/toe
 ;;^UTILITY(U,$J,358.3,19168,2)
 ;;=^272156
 ;;^UTILITY(U,$J,358.3,19169,0)
 ;;=715.90^^125^1231^7
 ;;^UTILITY(U,$J,358.3,19169,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19169,1,3,0)
 ;;=3^715.90
 ;;^UTILITY(U,$J,358.3,19169,1,5,0)
 ;;=5^Osteoarthrosis, unspecified whether generalized or localized
 ;;^UTILITY(U,$J,358.3,19169,2)
 ;;=^272161
 ;;^UTILITY(U,$J,358.3,19170,0)
 ;;=730.07^^125^1231^8
 ;;^UTILITY(U,$J,358.3,19170,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19170,1,3,0)
 ;;=3^730.07
 ;;^UTILITY(U,$J,358.3,19170,1,5,0)
 ;;=5^Osteomyelitis, Acute; ankle/foot/toe
 ;;^UTILITY(U,$J,358.3,19170,2)
 ;;=^272619
 ;;^UTILITY(U,$J,358.3,19171,0)
 ;;=730.17^^125^1231^9
 ;;^UTILITY(U,$J,358.3,19171,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19171,1,3,0)
 ;;=3^730.17
 ;;^UTILITY(U,$J,358.3,19171,1,5,0)
 ;;=5^Osteomyelitis, Chronic; ankle/foot/toe
 ;;^UTILITY(U,$J,358.3,19171,2)
 ;;=^272628
 ;;^UTILITY(U,$J,358.3,19172,0)
 ;;=730.27^^125^1231^10
 ;;^UTILITY(U,$J,358.3,19172,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19172,1,3,0)
 ;;=3^730.27
 ;;^UTILITY(U,$J,358.3,19172,1,5,0)
 ;;=5^Osteomyelitis, Unspecified; ankle/foot/toe
 ;;^UTILITY(U,$J,358.3,19172,2)
 ;;=^272637
 ;;^UTILITY(U,$J,358.3,19173,0)
 ;;=732.5^^125^1231^11
 ;;^UTILITY(U,$J,358.3,19173,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19173,1,3,0)
 ;;=3^732.5
 ;;^UTILITY(U,$J,358.3,19173,1,5,0)
 ;;=5^Osteochondrosis/Apophysitis, Juvenile; foot
